VNTH Archives - Page 3 of 4 - Blue Horseshoe Stocks

Biggest Options Gainers & More

Options Recaps:

We’ve gotten off to another great start with regard to options trading this week. Yesterday morning in our premarket report, we formulated a couple of ideas, in the THO and UNFI chains on the heels of those companies’ earnings reports.

Despite an extremely poor session for the markets in general yesterday, both of our our ideas, the THO 10/15 $115-120 Calls and the UNFI 10/15 $35-40 Calls, bucked the trend and exhibited multibag gains on the day for us. A strong performance all around no matter which contract set within our targeted ranges was selected.

Here are those excellent multibag intraday moves posted by our plays:

THO 10/15 $115-120 Calls
$115: 4.40-12.70 (+187%)
$120: 2.10-8.70 (+314%)
_____

UNFI 10/15 $35-40 Calls
$35: 5.00-12.32 (+146%)
$40: .1.60-7.57 (+373%)

Fresh Options Ideas:
MU Weekly $72-71 Puts
WOR 10/15 $60-65 Calls

Farmmi, Inc. FAMI

We also would like to designate FAMI as a longer-term bottom bouncer that has the potential to become a solid recovery play.

We are going to radar FAMI for the effort the company is making to get its stock back to the dollar minimum PPS required for continued listing on the NASDAQ. A shareholder letter from the CEO this morning outlined some of the ways that’s happening, including planned acquisitions and more. (>>Read PR)

Extended Watchlist:
ENZC, IFAN, TLSS, FERN, VNTH, FONU, ETEK, AYVU, NCNA, GOVX, ITRM, FOLD

Fresh Ideas, Special Reminder & More

eXp World Holdings Inc. EXPI – Update:

We apologize for any inconvenience due the absence of a morning report yesterday. We took an extremely rare day off in celebration of our 10-year anniversary of maintaining BlueHorseShoeStocks.com as the archive to all of our newsletters. You can visit there right now and still retrieve every single report we’ve published since August of 2011!

This morning, we’re going to jump right back into the mix with an update on our EXPI Calls, which we’ve been tracking since last Wednesday morning’s report, the EXPI 08/20 $40-45 Calls. In another update on Friday morning, we also rolled up our strike area to include the EXPI 08/20 $50 Calls as well.

Thanks to a fourth straight session in which EXPI registered new highs, yesterday we saw the following highs in our tracked plays. Here are the total possible profits we’ve witnessed so far in these targets that still have another week and a half before expiration:

EXPI 08/20 $40-50 Calls
$40: 1.55-14.40 (+829%)
$45: 1.30-9.30 (+615%)
$50: 1.86-5.30 (+185%)
_____

Fresh Options Ideas:
AMC Weekly $35-37 Calls
CHGG 08/20 $80-85 Calls
SYY Weekly $75-76.50 Calls

Special Reminder:

Just to give our loyal readers a heads up, we will be presenting a special report on a rapid-growth company tomorrow morning that we wouldn’t recommend missing! Make sure to stay glued to those inboxes around the typical time.

We’re excited about not only the direction this soon to be featured company is headed, but also the opportunity presented by its current chart setup. See you bright and early tomorrow!

Extended Watchlist:
ZEV, IMV, DYNT, FULC, FSR, ARCT, INQD, GXXM, APHLF, VNTH, SPQS, JNSH, BANI

Kicking Off a Potential-Filled Trading Week

Near-Perfect Options Performance:

Our incredible run of quick-strike options success continued on Friday, and continues to be an ongoing source of pride for us, not to mention a golden opportunity for our followers. As a matter of course, we formulated several options ideas based off of Friday earnings reports, which were spread across the CL, AZN, and ABBV chains.

Out of twelve possible strike points, we hit on eleven winners. Our specific targets were the CL Weekly $80-81.50 Calls, the AZN Weekly $52-53.50 Calls, and the ABBV Weekly $110-113 Calls. Every contract set, exception of the CL $81.50’s, produced impressive intraday profit chances. Those lofty figures were as follows:

CL Weekly $80-81.50 Calls
$80: .05-1.17 (+2240%)
$80.50: .40-.72 (+80%)
$81: .05-.40 (+800%)
$81.50: (Too far out of the $)
_____

AZN Weekly $52-53.50 Calls
$52: 1.00-2.39 (+139%)
$52.50: .61-1.82 (+198%)
$53: .65-1.50 (+131%)
$53.50: .25-1.10 (+340%)
_____

ABBV Weekly $110-113 Calls
$110: 1.00-2.35 (+135%)
$111: .45-1.50 (+233%)
$112: .27-.85 (+215%)
$113: .10-.40 (+300%)

Fresh Options Ideas:
RIOT Weekly $42-44 Calls
MARA Weekly $37.50-39 Calls
PQG 05/21 $15 Calls

Extended Watchlist:
HVBTF, BFARF, TXMD, FERN, ICBU, MVNT, BOTY, VNTH, COWI

Form-4 Alert & More

Options Update

Following up with our fresh options ideas from yesterday morning’s premarket report, we already saw some nice moves in the SPY Weekly $324-325 Calls and the AAPL 10/09 $105-106 Calls and, chances are, we are going to see some further increases today as well.

Here is what they’ve managed so far, and take note that we also want to add the AAPL 10/09 $110 Calls into the mix as well.

SPY Weekly $324-325 Calls
$324: 3.17-5.96 (+88%)
$325: 2.71-5.26 (+94%)
_____

AAPL 10/09 $105-106 Calls
$105: 4.25-8.07 (+90%)
$106: 4.00-7.45 (+86%)
_____

Fresh Options Ideas:
AZO Weekly $12.25 Calls

89Bio, Inc. ETNB

We are going to place ENTB on a bottom watch today after noticing a large Form-4 purchase toward the end of last week. A company director picked up an additional 1.3M shares at $28. Right now ENTB in trading in the $25-range.

This is an example of the kind of play we put on a longer term watch, despite most of our ideas being based on quick-strike opportunities.

Extended Watchlist:
ALYI, VNTH, GRST, HIRU, NPHC, JADA

Blue Horseshoe Stocks: NFLX, MCD Options Recaps & More

Options Recaps

Netflix, Inc. NFLX – We persisted in tracking the NFLX options idea that we formulated on Tuesday for the remainder of the week, and they ended up performing great yet again on Friday. If you recall, our designated targets were the NFLX Weekly $117-120 Calls, and they didn’t have a down day all week.

The following figures indicate the lows we observed on Tuesday morning, and the subsequent highs reached during Friday’s session. What we were faced with were four incredible intraweek increases:

$117 Calls – Range: 2.19-10.77 – Max Gain: 392%
$118 Calls – Range: 1.43-10.02 – Max Gain: 601%
$119 Calls – Range: 1.03-8.87 – Max Gain: 761%
$120 Calls – Range: 1.07-7.83 – Max Gain: 631%

______

McDonalds Corp. MCD – Our highlighted range of MCD Weekly $113-115 Calls was fresh for Friday’s session, and it bore fruit as well. While we didn’t sweep the range in terms of hefty gains, the $113’s in particular did provide a nice chance to profit on the day.

Those calls traded in a range from .33 and shot to 1.43, allowing for single-session gains of up to 333%

Agritek Holdings, Inc. AGTK

Subsequent to the alert we put out on AGTK last month on the 14th, we would observe an overall low of .003, and the stock has never fallen below that level since. In fact, what began as a subpenny play, has rumbled its way to multiple pennies after a fantastic performance last week.

Running to a new high of .0298 on Friday, the stock registered an overall increase of 893% over our observed low, and with a strong close at .028, we’ll be on the lookout for some momentum spillover into this week. The possibility of a dip-and-rip forming on the chart also appears to be a plausible scenario, so we’ll be on our toes watching for that possibility as well.

AGTK is also a part of the cannabis sector, which of course we’ve been watching more intently, and plan to continue doing so leading into election day the week after next.

Peregrine Pharmaceuticals, Inc. PPHM

This is another familiar play for us, and we want to tag it for closer observation again this morning on the strength of both a fresh PR hitting the wires along with an attractive technical setup on the chart.

As you can see below, the stock has recorded a higher low in each of the last five sessions since coming off a bottom, and indicators suggest that things could heat up for this play at any time. We’ll keep an eye peeled.

TODAY’S NEWS:
Preclinical Research Demonstrates Peregrine Pharmaceuticals’ PS-Targeting Antibodies Enhance the Anti-Tumor Activity of PD-L1 Checkpoint Inhibitors in Model of Triple Negative Breast Cancer (TNBC)(>>Read PR)

Extended Watchlist:
IFAN, PLPL, PPCH, PPJE, OPGN, DRWI, NEWC, VNTH